Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

被引：23

作者：

Doebar, Shusma C. ^{[1
]}

Slaets, Leen ^{[2
]}

Cardoso, Fatima ^{[3
]}

Giordano, Sharon H. ^{[4
,5
]}

Bartlett, John M. S. ^{[6
,7
]}

Tryfonidis, Konstantinos

Dijkstra, Nizet H. ^{[8
]}

Schroder, Caroline P. ^{[8
,9
]}

van Asperen, Christi J. ^{[8
,10
]}

Linderholm, Barbro ^{[11
]}

Benstead, Kim ^{[12
]}

Dinjens, Winan N. M. ^{[1
]}

van Marion, Ronald ^{[1
]}

van Diest, Paul J. ^{[13
]}

Martens, John W. M. ^{[8
,14
]}

van Deurzen, Carolien H. M. ^{[1
,8
]}

机构：

[1] Erasmus Univ, Erasmus MC Canc Inst, Dept Pathol, Med Ctr, Rotterdam, Netherlands

[2] European Org Res & Treatment Canc Headquarters, Brussels, Belgium

[3] Champalimaud Fdn, Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal

[4] Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

[6] Ontario Inst Canc Res, Transformat Pathol, Toronto, ON, Canada

[7] Univ Edinburgh, Edinburgh, Midlothian, Scotland

[8] Dutch Breast Canc Res Grp, BOOG Study Ctr, Amsterdam, Netherlands

[9] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands

[10] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands

[11] Sahlgrens Univ Hosp, Dept Oncol, SABO, Gothenburg, Sweden

[12] Cheltenham Gen Hosp, Dept Oncol, Cheltenham, Glos, England

[13] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands

[14] Erasmus Univ, Erasmus MC Canc Inst, Dept Med Oncol & Canc Genom Netherlands, Med Ctr, Rotterdam, Netherlands

来源：

MODERN PATHOLOGY | 2017年 / 30卷 / 04期

关键词：

CARCINOMA IN-SITU; DUCTAL CARCINOMA; GALAXY;

D O I：

10.1038/modpathol.2016.229

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

In men, data regarding breast cancer carcinogenesis are limited. The aim of our study was to describe the presence of precursor lesions adjacent to invasive male breast cancer, in order to increase our understanding of carcinogenesis in these patients. Central pathology review was performed for 1328 male breast cancer patients, registered in the retrospective joint analysis of the International Male Breast Cancer Program, which included the presence and type of breast cancer precursor lesions. In a subset, invasive breast cancer was compared with the adjacent precursor lesion by immunohistochemistry (n=83) or targeted next generation sequencing (n=7). Additionally, we correlated the presence of ductal carcinoma in situ with outcome. A substantial proportion (46.2%) of patients with invasive breast cancer also had an adjacent precursor lesion, mainly ductal carcinoma in situ (97.9%). The presence of lobular carcinoma in situ and columnar cell-like lesions were very low ( <1%). In the subset of invasive breast cancer cases with adjacent ductal carcinoma in situ (n=83), a complete concordance was observed between the estrogen receptor, progesterone receptor, and HER2 status of both components. Next generation sequencing on a subset of cases with invasive breast cancer and adjacent ductal carcinoma in situ (n=4) showed identical genomic aberrations, including PIK3CA, GATA3, TP53, and MAP2K4 mutations. Next generation sequencing on a subset of cases with invasive breast cancer and an adjacent columnar cell-like lesion showed genomic concordance in two out of three patients. A multivariate Cox model for survival showed a trend that the presence of ductal carcinoma in situ was associated with a better overall survival, in particular in the Luminal B HER2+ subgroup. In conclusion, ductal carcinoma in situ is the most commonly observed precursor lesion in male breast cancer and its presence seems to be associated with a better outcome, in particular in Luminal B HER2+ cases. The rate of lobular carcinoma in situ and columnar cell-like lesions adjacent to male breast cancer is very low, but our findings support the role of columnar cell-like lesions as a precursor of male breast cancer.

引用

页码：509 / 518

页数：10

共 25 条

[1] Is male breast cancer similar or different than female breast cancer? [J].

Anderson, WF ;

Althuis, MD ;

Brinton, LA ;

Devesa, SS .

BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (01) :77-86

[2] Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer [J].

Anderson, William F. ;

Jatoi, Ismail ;

Tse, Julia ;

Rosenberg, Philip S. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :232-239

[3] Sequence analysis of mutations and translocations across breast cancer subtypes [J].

Banerji, Shantanu ;

Cibulskis, Kristian ;

Rangel-Escareno, Claudia ;

Brown, Kristin K. ;

Carter, Scott L. ;

Frederick, Abbie M. ;

Lawrence, Michael S. ;

Sivachenko, Andrey Y. ;

Sougnez, Carrie ;

Zou, Lihua ;

Cortes, Maria L. ;

Fernandez-Lopez, Juan C. ;

Peng, Shouyong ;

Ardlie, Kristin G. ;

Auclair, Daniel ;

Bautista-Pina, Veronica ;

Duke, Fujiko ;

Francis, Joshua ;

Jung, Joonil ;

Maffuz-Aziz, Antonio ;

Onofrio, Robert C. ;

Parkin, Melissa ;

Pho, Nam H. ;

Quintanar-Jurado, Valeria ;

Ramos, Alex H. ;

Rebollar-Vega, Rosa ;

Rodriguez-Cuevas, Sergio ;

Romero-Cordoba, Sandra L. ;

Schumacher, Steven E. ;

Stransky, Nicolas ;

Thompson, Kristin M. ;

Uribe-Figueroa, Laura ;

Baselga, Jose ;

Beroukhim, Rameen ;

Polyak, Kornelia ;

Sgroi, Dennis C. ;

Richardson, Andrea L. ;

Jimenez-Sanchez, Gerardo ;

Lander, Eric S. ;

Gabriel, Stacey B. ;

Garraway, Levi A. ;

Golub, Todd R. ;

Melendez-Zajgla, Jorge ;

Toker, Alex ;

Getz, Gad ;

Hidalgo-Miranda, Alfredo ;

Meyerson, Matthew .

NATURE, 2012, 486 (7403) :405-409

[4] Medical progress - Ductal carcinoma in situ of the breast [J].

Burstein, HJ ;

Polyak, K ;

Wong, JS ;

Lester, SC ;

Kaelin, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1430-1441

[5] Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program [J].

Cardoso, Fatima ;

Bartlett, John ;

Slaets, Leen ;

van Deurzen, Carolien ;

van Leewen-Stok, Elise ;

Porter, Peggy ;

Linderholm, Barbro ;

Hedenfalk, Ingrid ;

Schroder, Carolien ;

Martens, John ;

Bayani, Jane ;

van Asperen, Christi ;

Murray, Melissa ;

Hudis, Clifford ;

Middleton, Lavinia ;

Vermeij, Joanna ;

Peeters, Stephanie ;

Fraser, Judith ;

Nowaczyk, Monica ;

Rubio, Isabel ;

Aebi, Stefan ;

Kelly, Catherine ;

Ruddy, Kathryn ;

Winer, Eric ;

Nilsson, Cecilia ;

Dal Lago, Lissandra ;

Korde, Larissa ;

Benstead, Kim ;

Van Den Weyngaert, Danielle ;

Bogler, Oliver ;

Goulioti, Theodora ;

Dif, Nicolas ;

Messina, Carlo ;

Tryfonidis, Konstantinos ;

Bogaerts, Jan ;

Giordano, Sharon .

CANCER RESEARCH, 2015, 75

[6] Ductal carcinoma in situ of the male breast. Analysis of 31 cases [J].

Cutuli, B ;

Dilhuydy, JM ;

DeLafontan, B ;

Berlie, J ;

Lacroze, M ;

Lesaunier, F ;

Graic, Y ;

Tortochaux, J ;

Resbeut, M ;

Lesimple, T ;

Gamelin, E ;

Campana, F ;

RemeSaumon, M ;

MonchoBernier, V ;

Cuilliere, JC ;

Marchal, C ;

DeGislain, G ;

NGuyen, TD ;

Teissier, E ;

Velten, M .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) :35-38

[7] Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival [J].

Dieterich, M. ;

Hartwig, F. ;

Stubert, J. ;

Kloecking, S. ;

Kundt, G. ;

Stengel, B. ;

Reimer, T. ;

Gerber, B. .

BREAST, 2014, 23 (04) :346-351

[8] Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study [J].

Doebar, Shusma C. ;

van den Broek, Esther C. ;

Koppert, Linetta B. ;

Jager, Agnes ;

Baaijens, Margreet. H. A. ;

Obdeijn, Inge-Marie A. M. ;

van Deurzen, Carolien H. M. .

BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) :179-187

[9] PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].

ELSTON, CW ;

ELLIS, IO .

HISTOPATHOLOGY, 1991, 19 (05) :403-410

[10] Male breast cancer [J].

Fentiman, IS ;

Fourquet, A ;

Hartobagyi, GN .

LANCET, 2006, 367 (9510) :595-604

← 1 2 3 →